Tumor-feeding artery diameter reduction is associated with improved short-term effect of hepatic arterial infusion chemotherapy plus lenvatinib treatment

Table 2 Receiver-operating characteristic analysis for antitumor response

Δartery	1 mo			3 mo			6 mo
	Responder	Non- responder	P value	Responder	Non- responder	P value	Responder	Non- responder	P value
CHA	- (0.17 ± 0.17)	- (0.14 ± 0.18)	0.25	- (0.15 ± 0.16)	- (0.18 ± 0.19)	1.00	- (0.18 ± 0.16)	- (0.15 ± 0.18)	0.51
PHA	- (0.21 ± 0.14)	- (0.13 ± 0.25)	0.15	- (0.20 ± 0.15)	- (0.16 ± 0.20)	0.35	- (0.16 ± 0.16)	- (0.22 ± 0.17)	0.30
LHA	- (0.27 ± 0.17)	- (0.21 ± 0.28)	0.59	(0.28 ± 0.18)	(0.20 ± 0.27)	0.43	- (0.22 ± 0.24)	- (0.30 ± 0.17)	0.18
RHA	- (0.22 ± 0.17)	- (0.16 ± 0.23)	0.26	- (0.20 ± 0.19)	- (0.22 ± 0.20)	0.58	- (0.16 ± 0.23)	- (0.24 ± 0.17)	0.44
TFA	- (0.33 ± 0.20)	- (0.16 ± 0.19)	< 0.001	- (0.32 ± 0.19)	- (0.18 ± 0.22)	0.004	- (0.36 ± 0.16)	- (0.25± 0.23)	0.023

Δ_artery: The rate of change in vessel diameters of hepatic arteries; CHA: Common hepatic artery; PHA: Proper hepatic artery; LHA: Left hepatic artery; RHA: Right hepatic artery; TFA: Tumor-feeding artery.